NOK 18.75
(1.35%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 11.69 Million NOK | 946.01% |
2022 | 99.02 Million USD | -79.65% |
2021 | 49.09 Million NOK | 151.8% |
2020 | 21.7 Million NOK | 64.69% |
2019 | 12.17 Million NOK | 26875.58% |
2018 | -47.03 Thousand USD | 0.0% |
2010 | 17.74 Million NOK | 97.34% |
2009 | -24.54 Million NOK | 27.09% |
2008 | -30.3 Million NOK | 10.38% |
2007 | -46.85 Million NOK | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 823 Thousand NOK | -96.17% |
2024 Q3 | 1.38 Million USD | 68.29% |
2024 Q1 | 2.12 Million USD | -6.86% |
2023 Q3 | 2.04 Million USD | -42.26% |
2023 Q4 | 2.45 Million USD | 19.87% |
2023 FY | - NOK | 946.01% |
2023 Q1 | 3.64 Million USD | 16.54% |
2023 Q2 | 3.54 Million USD | -2.58% |
2022 Q4 | 3.12 Million USD | -90.2% |
2022 Q2 | 32.39 Million NOK | 103.71% |
2022 Q3 | 31.86 Million NOK | -1.61% |
2022 FY | - USD | -79.65% |
2022 Q1 | 15.9 Million NOK | -11.49% |
2021 Q1 | 11.81 Million USD | 50.5% |
2021 Q4 | 17.96 Million NOK | 67.96% |
2021 Q3 | 10.69 Million NOK | 12.98% |
2021 Q2 | 9.46 Million NOK | -19.9% |
2021 FY | - NOK | 151.8% |
2020 Q1 | -1.35 Million USD | 0.0% |
2020 FY | - NOK | 64.69% |
2020 Q4 | 7.85 Million NOK | -24.84% |
2020 Q3 | 10.44 Million NOK | 1448.26% |
2020 Q2 | -775 Thousand NOK | 42.67% |
2019 FY | - NOK | 26875.58% |
2018 FY | - USD | 0.0% |
2010 FY | - NOK | 97.34% |
2009 FY | - NOK | 27.09% |
2008 FY | - NOK | 10.38% |
2007 FY | - NOK | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Elliptic Laboratories ASA | -39.79 Million NOK | 129.378% |
Zwipe AS | -96.45 Million NOK | 112.12% |